Pulse Biosciences Inc (PLSE)
7.89
+0.63
(+8.68%)
USD |
NASDAQ |
May 16, 16:00
7.89
0.00 (0.00%)
After-Hours: 20:00
Pulse Biosciences Enterprise Value: 366.05M for May 15, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 15, 2024 | 366.05M |
| May 14, 2024 | 389.80M |
| May 13, 2024 | 359.98M |
| May 10, 2024 | 376.54M |
| May 09, 2024 | 348.93M |
| May 08, 2024 | 346.17M |
| May 07, 2024 | 384.83M |
| May 06, 2024 | 392.01M |
| May 03, 2024 | 396.98M |
| May 02, 2024 | 409.68M |
| May 01, 2024 | 384.83M |
| April 30, 2024 | 372.13M |
| April 29, 2024 | 365.50M |
| April 26, 2024 | 362.18M |
| April 25, 2024 | 334.57M |
| April 24, 2024 | 343.96M |
| April 23, 2024 | 343.96M |
| April 22, 2024 | 343.41M |
| April 19, 2024 | 362.18M |
| April 18, 2024 | 371.57M |
| April 17, 2024 | 377.65M |
| April 16, 2024 | 394.77M |
| April 15, 2024 | 396.98M |
| April 12, 2024 | 363.84M |
| April 11, 2024 | 366.05M |
| Date | Value |
|---|---|
| April 10, 2024 | 374.33M |
| April 09, 2024 | 380.96M |
| April 08, 2024 | 380.41M |
| April 05, 2024 | 383.17M |
| April 04, 2024 | 385.38M |
| April 03, 2024 | 403.60M |
| April 02, 2024 | 389.80M |
| April 01, 2024 | 406.37M |
| March 28, 2024 | 436.65M |
| March 27, 2024 | 419.53M |
| March 26, 2024 | 411.24M |
| March 25, 2024 | 427.26M |
| March 22, 2024 | 450.45M |
| March 21, 2024 | 476.41M |
| March 20, 2024 | 476.96M |
| March 19, 2024 | 469.58M |
| March 18, 2024 | 496.05M |
| March 15, 2024 | 524.17M |
| March 14, 2024 | 520.31M |
| March 13, 2024 | 547.89M |
| March 12, 2024 | 554.50M |
| March 11, 2024 | 544.58M |
| March 08, 2024 | 487.23M |
| March 07, 2024 | 476.75M |
| March 06, 2024 | 468.75M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
30.87M
Minimum
Aug 30 2022
1.111B
Maximum
Feb 08 2021
301.01M
Average
260.33M
Median
Feb 07 2020
Enterprise Value Benchmarks
| Align Technology Inc | 20.20B |
| ThermoGenesis Holdings Inc | 8.908M |
| NeuroOne Medical Technologies Corp | 24.81M |
| SINTX Technologies Inc | 12.36M |
| Nutriband Inc | 55.11M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -10.14M |
| Total Expenses (Quarterly) | 10.62M |
| EPS Diluted (Quarterly) | -0.18 |
| Earnings Yield | -10.27% |
| Normalized Earnings Yield | -22.31 |